+491.9%
MRNA vs AVTR
+1.1%
+490.9%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | AVTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | 0.0% | +0.7% | +0.7% |
| 7D | -8.2% | -2.0% | -6.2% | -7.6% |
| 30D | +125.6% | +8.1% | +117.5% | +121.0% |
| 3M | +197.1% | +54.2% | +142.9% | +163.6% |
| 6M | +148.5% | +82.6% | +65.9% | +110.8% |
| YTD | +363.3% | +29.8% | +333.4% | +328.1% |
| 1Y | +462.0% | +18.0% | +444.0% | +424.1% |
| 3Y | +26.9% | -26.4% | +53.4% | +29.8% |
| 5Y | -69.6% | -64.8% | -4.8% | -66.9% |
| All | +491.9% | +1.1% | +490.9% | +641.8% |
Cumulative growth
Daily Returns
Daily percentage return beside AVTR.
Daily Out/Under-Performance
Portfolio return minus AVTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded AVTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling